Sri Anantha Padmanabha Swamy Pharma Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
- Paid Up Capital ₹ 7.60 Cr
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.16 Cr
- Revenue Growth 1.99%
- Profit Growth 153.58%
- Ebitda 16.72%
- Net Worth 32.61%
- Total Assets 11.39%
About Sri Anantha Padmanabha Swamy Pharma
Sri Anantha Padmanabha Swamy Pharma Private Limited (SAPSPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 April 2013 and has a history of 11 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 7.60 Cr.
The company currently has active open charges totaling ₹5.16 Cr.
Peddi Jagadishwar, Vallabadas Goud, Alok Agarwal, and Three other members serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2013PTC086824
-
Company No.
086824
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Apr 2013
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sri Anantha Padmanabha Swamy Pharma?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Peddi
|
Director | 07-Apr-2013 | Current |
|
Peddi Jagadishwar
|
Director | 07-Apr-2013 | Current |
|
Vallabadas Goud
|
Director | 07-Apr-2013 | Current |
|
Alok Agarwal
|
Director | 07-Apr-2013 | Current |
|
Bhaskar Karshikallam
|
Director | 07-Apr-2013 | Current |
|
Renu Goyal
|
Director | 07-Apr-2013 | Current |
Financial Performance of Sri Anantha Padmanabha Swamy Pharma.
Sri Anantha Padmanabha Swamy Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.99% increase. The company also saw a substantial improvement in profitability, with a 153.58% increase in profit. The company's net worth Soared by an impressive increase of 32.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Anantha Padmanabha Swamy Pharma?
In 2022, Sri Anantha Padmanabha Swamy Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sj Life Sciences Private LimitedPeddi Jagadishwar is a mutual person
-
Swati Herbals Limited
Alok Agarwal is a mutual person
-
Super Standard Tools And Equipments Private Limited
Alok Agarwal is a mutual person
-
Swati Manufacturers Private Limited
Alok Agarwal is a mutual person
-
Brighid Biologicals Private Limited
Naresh Peddi is a mutual person
Charges (Loans)
₹5.16 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 5.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2014 | State Bank Of India | ₹5.16 Cr | Open |
How Many Employees Work at Sri Anantha Padmanabha Swamy Pharma?
Sri Anantha Padmanabha Swamy Pharma has a workforce of 27 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Anantha Padmanabha Swamy Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Anantha Padmanabha Swamy Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.